Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01175356
Title Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group
Indications

neuroblastoma

ganglioneuroblastoma

Therapies

Busulfan + Melphalan

Cyclophosphamide + Topotecan

131I-MIBG

Cyclophosphamide + Doxorubicin + Vincristine Sulfate

Cisplatin + Etoposide

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.